HerbsTurmeric Wood (Curcuma longa)
Turmeric Wood (Curcuma longa): Health Benefits for Inflammation
Latest posts by Dr. Zahra Aghanouri, MD, PhD (see all)
- Are You Sleep Deficient? Find Your Herbal Sleep Aid Quiz - July 2, 2025
- The Truth About Women’s Hormones - June 29, 2025
- Cornmeal (Zea mays) - December 23, 2024
Introduction
Turmeric (Curcuma longa), often referred to as “Indian Saffron” or “Golden Spice,” is a vibrant yellow rhizomatous herbaceous perennial plant belonging to the ginger family (Zingiberaceae). Native to the Indian subcontinent and Southeast Asia, this remarkable spice has been a cornerstone of traditional medicine systems for over 4,000 years [1]. Archaeological evidence suggests that turmeric was cultivated in the Harappan civilization as early as 3000 BCE, highlighting its deep historical roots in human culture [2].
The plant grows to a height of about 3 feet (1 meter) and features long, oblong leaves and funnel-shaped yellow flowers. However, it’s the rhizome—the underground stem that grows horizontally and forms a complex root system—that contains turmeric’s prized medicinal compounds [3]. When harvested, cleaned, and dried, these rhizomes are typically ground into the distinctive golden-yellow powder that has become a staple in kitchens and medicine cabinets worldwide.
Turmeric’s journey from ancient remedy to modern therapeutic agent represents one of the most extensively researched natural products in contemporary science. Its transition from traditional Ayurvedic and Chinese medicine into evidence-based healthcare applications exemplifies the potential value of ethnobotanical knowledge in addressing modern health challenges [4].
Chemical Composition and Active Compounds
Turmeric’s therapeutic properties stem from its rich and complex phytochemical profile. The rhizome contains more than 100 components, including:
Curcuminoids
The most studied and pharmacologically significant compounds in turmeric are curcuminoids, which constitute approximately 2-5% of the rhizome by weight [5]. The three primary curcuminoids are:
•Curcumin (diferuloylmethane): Comprising approximately 77% of the curcuminoid content, curcumin is the principal active compound responsible for turmeric’s vibrant yellow color and many of its therapeutic effects [6].
•Demethoxycurcumin: Making up about 17% of curcuminoids, this compound works synergistically with curcumin [7].
•Bisdemethoxycurcumin: Constituting roughly 3% of curcuminoids, this compound also contributes to turmeric’s overall bioactivity [8].
Essential Oils
Turmeric contains 3-5% essential oils, primarily composed of sesquiterpenes, including:
•ar-Turmerone: The most abundant component, comprising approximately 25% of the essential oil [9].
•α-Turmerone and β-Turmerone: These compounds contribute to turmeric’s distinctive aroma and have demonstrated biological activities [10].
•Zingiberene: A sesquiterpene also found in ginger that contributes to turmeric’s aromatic profile [11].
Other Compounds
Turmeric also contains various polysaccharides, proteins, resins, and minerals that may contribute to its overall therapeutic profile [12]. Research suggests that these components may work synergistically with curcuminoids, potentially enhancing their bioavailability and efficacy [13].
Mechanisms of Anti-inflammatory Action
Inflammation is a complex biological response to harmful stimuli, such as pathogens, damaged cells, or irritants. While acute inflammation is a necessary protective mechanism, chronic inflammation contributes to numerous diseases, including arthritis, cardiovascular disease, and neurodegenerative disorders [14]. Turmeric, particularly its curcumin content, exhibits potent anti-inflammatory properties through multiple mechanisms:
Inhibition of Inflammatory Enzymes
Curcumin inhibits the activity of cyclooxygenase-2 (COX-2), lipoxygenase (LOX), and inducible nitric oxide synthase (iNOS)—enzymes involved in the inflammatory process [15]. By inhibiting these enzymes, curcumin reduces the production of prostaglandins, leukotrienes, and nitric oxide, which are key mediators of inflammation [16].
Modulation of Cytokines and Chemokines
Curcumin modulates the production and activity of various pro-inflammatory cytokines and chemokines, including tumor necrosis factor-alpha (TNF-α), interleukins (IL-1, IL-6, IL-8, IL-12), and monocyte chemoattractant protein-1 (MCP-1) [17]. A meta-analysis of randomized controlled trials found that curcumin supplementation significantly reduced circulating levels of IL-6, a major inflammatory marker [18].
Inhibition of NF-κB Activation
Nuclear factor-kappa B (NF-κB) is a transcription factor that regulates the expression of numerous genes involved in inflammation. Curcumin inhibits the activation and nuclear translocation of NF-κB, thereby suppressing the expression of various inflammatory mediators [19]. This mechanism is particularly significant as NF-κB activation is implicated in numerous chronic inflammatory conditions [20].
Modulation of MAPK Signaling
Mitogen-activated protein kinases (MAPKs) are involved in cellular responses to various stimuli, including inflammation. Curcumin modulates MAPK signaling pathways, particularly p38 MAPK and JNK, which are involved in the production of pro-inflammatory cytokines [21].
Antioxidant Effects
Oxidative stress and inflammation are closely interlinked processes. Curcumin’s potent antioxidant properties contribute to its anti-inflammatory effects by:
•Scavenging reactive oxygen species (ROS) and reactive nitrogen species (RNS) [22]
•Enhancing the activity of antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase [23]
•Increasing cellular glutathione levels, a major intracellular antioxidant [24]
A 2018 systematic review and meta-analysis of 15 randomized controlled trials found that curcumin supplementation significantly increased SOD activity and reduced malondialdehyde (MDA) levels, a marker of oxidative stress [25].
Health Benefits Supported by Scientific Evidence
Arthritis and Joint Health
Arthritis, characterized by joint inflammation and pain, affects millions worldwide. Multiple clinical studies have demonstrated turmeric’s efficacy in managing arthritis symptoms:
•A randomized, double-blind, placebo-controlled trial involving 107 patients with knee osteoarthritis found that curcumin (1,000 mg/day) was as effective as ibuprofen (1,200 mg/day) in reducing pain and improving function, with fewer gastrointestinal side effects [26].
•A 2016 systematic review and meta-analysis of eight randomized controlled trials concluded that curcumin supplementation significantly reduced arthritis symptoms compared to placebo, with effects comparable to certain non-steroidal anti-inflammatory drugs (NSAIDs) [27].
•A 2019 study found that curcumin reduced synovial fluid IL-1β and enhanced cartilage regeneration in patients with osteoarthritis [28].
The mechanisms underlying these benefits include inhibition of inflammatory mediators, reduction of oxidative stress in joint tissues, and modulation of chondrocyte metabolism [29].
Inflammatory Bowel Disease (IBD)
IBD, including Crohn’s disease and ulcerative colitis, involves chronic inflammation of the gastrointestinal tract. Turmeric has shown promise in managing IBD:
•A pilot study involving 89 patients with ulcerative colitis in remission found that curcumin (2 g/day) was superior to placebo in preventing disease relapse over six months (4.7% vs. 20.5% relapse rate) [30].
•A randomized, double-blind, placebo-controlled trial in 50 patients with mild-to-moderate ulcerative colitis found that curcumin (3 g/day) combined with mesalamine induced remission in 53.8% of patients compared to 12.5% in the placebo group [31].
•Mechanistic studies suggest that curcumin’s benefits in IBD stem from its ability to modulate intestinal barrier function, gut microbiota composition, and mucosal immune responses [32].
Metabolic Syndrome and Cardiovascular Health
Metabolic syndrome—characterized by abdominal obesity, hypertension, dyslipidemia, and insulin resistance—is associated with chronic low-grade inflammation. Turmeric may help manage various aspects of this condition:
•A meta-analysis of 20 randomized controlled trials found that curcumin supplementation significantly reduced C-reactive protein (CRP), a marker of systemic inflammation associated with cardiovascular risk [33].
•Multiple clinical trials have demonstrated curcumin’s ability to improve lipid profiles by reducing total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides while increasing high-density lipoprotein (HDL) cholesterol [34].
•Curcumin has been shown to improve endothelial function, reduce arterial stiffness, and lower blood pressure in patients with type 2 diabetes and metabolic syndrome [35].
•A 2019 randomized controlled trial found that curcumin supplementation (1,000 mg/day) for 12 weeks significantly improved insulin sensitivity and reduced fasting blood glucose in patients with metabolic syndrome [36].
Neurodegenerative Diseases
Chronic neuroinflammation plays a crucial role in the pathogenesis of neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. Turmeric’s neuroprotective effects have been investigated in various studies:
•Curcumin crosses the blood-brain barrier and has been shown to reduce amyloid-β and tau aggregation—key pathological features of Alzheimer’s disease—in both in vitro and animal studies [37].
•A randomized, double-blind, placebo-controlled trial in 40 patients with mild-to-moderate Alzheimer’s disease found that curcumin (4 g/day) for 24 weeks was safe and well-tolerated, with trends toward improved cognitive function [38].
•Curcumin protects against neuroinflammation by inhibiting microglial activation and reducing the production of pro-inflammatory cytokines in the central nervous system [39].
•Emerging evidence suggests that curcumin may enhance neurogenesis and synaptic plasticity, potentially contributing to cognitive benefits [40].
Cancer Prevention and Adjuvant Therapy
While not a standalone cancer treatment, substantial evidence suggests that turmeric may have chemopreventive properties and potential as an adjuvant therapy:
•Epidemiological studies have noted lower rates of certain cancers in populations with high turmeric consumption [41].
•Preclinical studies have demonstrated curcumin’s ability to inhibit carcinogenesis at various stages through multiple mechanisms, including modulation of cell signaling pathways, induction of apoptosis, and inhibition of angiogenesis [42].
•Clinical trials have investigated curcumin as an adjuvant to conventional cancer therapies, with some showing reduced side effects and improved quality of life [43].
•A phase II trial in 25 patients with advanced pancreatic cancer found that curcumin (8 g/day) was well-tolerated and demonstrated biological activity in some patients [44].
It’s important to note that while these findings are promising, more large-scale clinical trials are needed to establish turmeric’s role in cancer management definitively.
Bioavailability Challenges and Solutions
Despite its therapeutic potential, curcumin’s clinical efficacy is limited by its poor bioavailability due to:
•Low water solubility
•Rapid metabolism in the liver
•Extensive intestinal and hepatic glucuronidation and sulfation
•Limited intestinal permeability
•Rapid systemic elimination [45]
Studies have shown that orally administered curcumin results in very low serum concentrations, with most of the compound being excreted in feces [46]. To address these limitations, various strategies have been developed:
Piperine Combination
Piperine, the active component in black pepper, inhibits glucuronidation enzymes and intestinal P-glycoprotein, which are involved in curcumin metabolism and efflux. A study found that co-administration of piperine (20 mg) with curcumin (2 g) increased curcumin bioavailability by 2,000% in humans [47].
Lipid Formulations
Curcumin’s lipophilic nature makes lipid-based delivery systems effective for improving its bioavailability:
•Liposomal curcumin has demonstrated 4-5 times higher bioavailability compared to standard curcumin [48].
•Curcumin formulated with phosphatidylcholine has shown enhanced absorption and improved therapeutic efficacy in clinical trials [49].
Nanoparticle Formulations
Nanoparticle-based delivery systems significantly enhance curcumin’s bioavailability:
•A nano-curcumin formulation demonstrated approximately 27 times higher bioavailability than standard curcumin in a human pharmacokinetic study [50].
•Polymeric micelles, cyclodextrin inclusions, and solid lipid nanoparticles have all shown promise in improving curcumin delivery [51].
Water-Soluble Analogs
Chemical modifications to create water-soluble curcumin analogs have been developed to overcome solubility limitations while maintaining therapeutic activity [52].
Dosage and Safety Considerations
Recommended Dosage
Dosage recommendations for turmeric and curcumin vary based on the specific health condition and formulation:
•Standardized Curcumin Extracts: Most clinical studies have used doses ranging from 500 mg to 2,000 mg of curcumin per day, typically divided into multiple doses [53].
•Turmeric Powder: As a dietary supplement, 1.5 to 3 g of turmeric powder daily is commonly recommended [54].
•Enhanced Bioavailability Formulations: Lower doses may be effective when using formulations with improved bioavailability. For example, 200-500 mg of curcumin phytosome has shown efficacy in clinical trials [55].
It’s important to note that turmeric used as a culinary spice (typically 1-3 g per day) provides much lower amounts of curcumin than those used in clinical studies.
Safety Profile
Turmeric and curcumin have demonstrated an excellent safety profile in both preclinical and clinical studies:
•The U.S. Food and Drug Administration (FDA) has classified turmeric as Generally Recognized As Safe (GRAS) [56].
•A comprehensive review of clinical trials found that curcumin is well-tolerated at doses up to 12 g per day, with only mild gastrointestinal symptoms reported in some cases [57].
•A 2017 systematic review of 22 randomized controlled trials concluded that adverse events related to curcumin supplementation were not significantly different from placebo [58].
Potential Side Effects
While generally safe, some individuals may experience:
•Mild gastrointestinal symptoms (nausea, diarrhea, stomach upset)
•Allergic reactions (rare)
•Increased risk of bleeding when combined with anticoagulant medications
•Potential iron chelation with high doses [59]
Drug Interactions
Turmeric may interact with certain medications:
•Anticoagulants and Antiplatelets: Curcumin may enhance the effects of these medications, potentially increasing bleeding risk [60].
•Diabetes Medications: Curcumin may enhance the blood glucose-lowering effect of these drugs, potentially causing hypoglycemia [61].
•Acid-Reducing Medications: Turmeric may increase stomach acid production, potentially counteracting the effects of these medications [62].
Individuals taking prescription medications should consult with a healthcare provider before beginning turmeric supplementation.
Conclusion
Turmeric, particularly its active compound curcumin, represents one of nature’s most powerful anti-inflammatory agents with a remarkable safety profile. The extensive scientific research supporting its therapeutic potential in various inflammatory conditions—from arthritis to inflammatory bowel disease to neurodegenerative disorders—highlights its value in both traditional and modern healthcare approaches.
While bioavailability challenges have historically limited curcumin’s clinical efficacy, innovative formulation strategies have largely overcome these obstacles, making this ancient remedy more accessible and effective than ever before. As research continues to elucidate turmeric’s mechanisms of action and optimal therapeutic applications, this golden spice stands as a promising complementary approach for managing inflammatory conditions and promoting overall health.
For those considering turmeric supplementation, consulting with a healthcare provider is recommended, particularly for individuals with pre-existing health conditions or those taking medications. When properly incorporated into a comprehensive health regimen, turmeric offers a natural, evidence-based option for addressing inflammation and its associated health challenges.
References
[1] Prasad S, Aggarwal BB. Turmeric, the Golden Spice: From Traditional Medicine to Modern Medicine. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 13.
[2] Ravindran PN, Nirmal Babu K, Sivaraman K. Turmeric: The Genus Curcuma. CRC Press; 2007.
[3] Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK. Turmeric and curcumin: Biological actions and medicinal applications. Current Science. 2004;87(1):44-53.
[4] Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013;15(1):195-218.
[5] Jayaprakasha GK, Rao LJ, Sakariah KK. Chemistry and biological activities of C. longa. Trends in Food Science & Technology. 2005;16(12):533-548.
[6] Anand P, Thomas SG, Kunnumakkara AB, et al. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol. 2008;76(11):1590-1611.
[7] Sandur SK, Pandey MK, Sung B, et al. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis. 2007;28(8):1765-1773.
[8] Kiuchi F, Goto Y, Sugimoto N, Akao N, Kondo K, Tsuda Y. Nematocidal activity of turmeric: synergistic action of curcuminoids. Chem Pharm Bull (Tokyo). 1993;41(9):1640-1643.
[9] Nishiyama T, Mae T, Kishida H, et al. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. J Agric Food Chem. 2005;53(4):959-963.
[10] Liju VB, Jeena K, Kuttan R. An evaluation of antioxidant, anti-inflammatory, and antinociceptive activities of essential oil from Curcuma longa L. Indian J Pharmacol. 2011;43(5):526-531.
[11] Rathore P, Dohare P, Varma S, et al. Curcuma oil: reduces early accumulation of oxidative product and is anti-apoptogenic in transient focal ischemia in rat brain. Neurochem Res. 2008;33(9):1672-1682.
[12] Li S, Yuan W, Deng G, Wang P, Yang P, Aggarwal BB. Chemical composition and product quality control of turmeric (Curcuma longa L.). Pharmaceutical Crops. 2011;2:28-54.
[13] Gopi S, Jacob J, Varma K, et al. Comparative Oral Absorption of Curcumin in a Natural Turmeric Matrix with Two Other Curcumin Formulations: An Open-label Parallel-arm Study. Phytother Res. 2017;31(12):1883-1891.
[14] Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822-1832.
[15] Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol. 2007;595:105-125.
[16] Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med. 2003;9(1):161-168.
[17] Shehzad A, Rehman G, Lee YS. Curcumin in inflammatory diseases. Biofactors. 2013;39(1):69-77.
[18] Derosa G, Maffioli P, Simental-Mendía LE, Bo S, Sahebkar A. Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2016;111:394-404.
[19] Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41(1):40-59.
[20] Gupta SC, Sundaram C, Reuter S, Aggarwal BB. Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta. 2010;1799(10-12):775-787.
[21] Kim YS, Ahn Y, Hong MH, et al. Curcumin attenuates inflammatory responses of TNF-alpha-stimulated human endothelial cells. J Cardiovasc Pharmacol. 2007;50(1):41-49.
[22] Ak T, Gülçin I. Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact. 2008;174(1):27-37.
[23] Biswas SK, McClure D, Jimenez LA, Megson IL, Rahman I. Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signal. 2005;7(1-2):32-41.
[24] Trujillo J, Chirino YI, Molina-Jijón E, Andérica-Romero AC, Tapia E, Pedraza-Chaverrí J. Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biol. 2013;1:448-456.
[25] Tabrizi R, Vakili S, Akbari M, et al. The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2019;33(2):253-262.
[26] Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin Interv Aging. 2014;9:451-458.
[27] Daily JW, Yang M, Park S. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food. 2016;19(8):717-729.
[28] Henrotin Y, Malaise M, Wittoek R, et al. Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study. Arthritis Res Ther. 2019;21(1):179.
[29] Henrotin Y, Priem F, Mobasheri A. Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management. Springerplus. 2013;2(1):56.
[30] Hanai H, Iida T, Takeuchi K, et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2006;4(12):1502-1506.
[31] Lang A, Salomon N, Wu JC, et al. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2015;13(8):1444-1449.e1.
[32] Lopresti AL. The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects? Adv Nutr. 2018;9(1):41-50.
[33] Sahebkar A. A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels. Clin Nutr. 2014;33(3):406-414.
[34] Qin S, Huang L, Gong J, et al. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials. Nutr J. 2017;16(1):68.
[35] Akazawa N, Choi Y, Miyaki A, et al. Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women. Nutr Res. 2012;32(10):795-799.
[36] Panahi Y, Khalili N, Sahebi E, et al. Effects of Curcuminoids Plus Piperine on Glycemic, Hepatic and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Placebo-Controlled Trial. Drug Res (Stuttg). 2018;68(7):403-409.
[37] Yang F, Lim GP, Begum AN, et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005;280(7):5892-5901.
[38] Baum L, Lam CW, Cheung SK, et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol. 2008;28(1):110-113.
[39] Ghasemi F, Bagheri H, Barreto GE, Read MI, Sahebkar A. Effects of Curcumin on Microglial Cells. Neurotox Res. 2019;36(1):12-26.
[40] Xu Y, Ku B, Tie L, et al. Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Res. 2006;1122(1):56-64.
[41] Nagpal M, Sood S. Role of curcumin in systemic and oral health: An overview. J Nat Sci Biol Med. 2013;4(1):3-7.
[42] Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008;269(2):199-225.
[43] Hejazi J, Rastmanesh R, Taleban FA, Molana SH, Ehtejab G. A Pilot Clinical Trial of Radioprotective Effects of Curcumin Supplementation in Patients with Prostate Cancer. J Cancer Sci Ther. 2013;5(10):320-324.
[44] Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008;14(14):4491-4499.
[45] Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807-818.
[46] Sharma RA, Steward WP, Gescher AJ. Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol. 2007;595:453-470.
[47] Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64(4):353-356.
[48] Sasaki H, Sunagawa Y, Takahashi K, et al. Innovative preparation of curcumin for improved oral bioavailability. Biol Pharm Bull. 2011;34(5):660-665.
[49] Cuomo J, Appendino G, Dern AS, et al. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod. 2011;74(4):664-669.
[50] Sasaki H, Sunagawa Y, Takahashi K, et al. Innovative preparation of curcumin for improved oral bioavailability. Biol Pharm Bull. 2011;34(5):660-665.
[51] Naksuriya O, Okonogi S, Schiffelers RM, Hennink WE. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials. 2014;35(10):3365-3383.
[52] Pabon HJ. A synthesis of curcumin and related compounds. Recl Trav Chim Pays Bas. 1964;83(4):379-386.
[53] Hewlings SJ, Kalman DS. Curcumin: A Review of Its Effects on Human Health. Foods. 2017;6(10):92.
[54] Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013;15(1):195-218.
[55] Belcaro G, Cesarone MR, Dugall M, et al. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev. 2010;15(4):337-344.
[56] U.S. Food and Drug Administration. GRAS Substances (SCOGS) Database. Available at: https://www.fda.gov/food/generally-recognized-safe-gras/gras-substances-scogs-database.
[57] Lao CD, Ruffin MT 4th, Normolle D, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006;6:10.
[58] Sahebkar A, Serban MC, Ursoniu S, Banach M. Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials. J Funct Foods. 2015;18:898-909.
[59] Bahramsoltani R, Rahimi R, Farzaei MH. Pharmacokinetic interactions of curcuminoids with conventional drugs: A review. J Ethnopharmacol. 2017;209:1-12.
[60] Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm. 2000;57(13):1221-1227.
[61] Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care. 2012;35(11):2121-2127.
[62] Rajasekaran SA. Therapeutic potential of curcumin in gastrointestinal diseases. World J Gastrointest Pathophysiol. 2011;2(1):1-14.
